Skip to main content
. 2017 Nov 1;52(1):127–138. doi: 10.3892/ijo.2017.4183

Figure 3.

Figure 3

Rg3 represses growth and stemness of colorectal cancer (CRC) cells in vivo. (A) Images of resected LoVo and SW620 orthotopic xenografts. Mice bearing LoVo or SW620 orthotopic xenografts were randomly divided into two groups (five mice in each group): The Rg3 group, which received Rg3 by gastric perfusion daily (25 mg/kg) for 12 consecutive days, and the control group, which was treated with normal saline. (B) Tumor weights of resected LoVo and SW620 orthotopic xenografts. (C–J) Immunohistochemical examination of Ki-67 (C and D), CD24 (E and F), CD44 (G and H) and EpCAM (I and J) levels in LoVo and SW620 orthotopic xenografts. *P<0.05 and **P<0.01 indicate significant differences compared with the respective control groups.